TY - JOUR
T1 - Cocaine blocks HERG, but not KvLQT1+minK, potassium channels
AU - Zhang, Shetuan
AU - Rajamani, Sridharan
AU - Chen, Yuenmu
AU - Gong, Qiuming
AU - Rong, Yajing
AU - Zhou, Zhengfeng
AU - Ruoho, Arnold
AU - January, Craig T.
PY - 2001
Y1 - 2001
N2 - Cocaine causes cardiac arrhythmias, sudden death, and occasionally long QT syndrome in humans. We investigated the effect of cocaine on the human K+ channels HERG and KvLQT1+mink that encode native rapidly (IKr) and slowly (lKs) activating delayed rectifier K+ channels in the heart. HERG and KvLQT1+mink channels were heterologously expressed in human embryonic kidney 293 cells, and whole-cell currents were recorded. Cocaine had no effect on KvLQT1+mink current in concentrations up to 200 μM. In contrast, cocaine reversibly blocked HERG current with half-maximal block of peak tail current of 7.2 μM. By using a protocol to quickly activate HERG channels, we found that cocaine block developed rapidly after channel activation. At 0 mV, the time constants for the development of block were 38.2 ± 2.1, 15.2 ± 0.8, and 6.9 ± 1.1 ms in 10, 50 and 200 μM cocaine, respectively. Cocaine-blocked channels also recovered rapidly from block after repolarization. At -100 mV, recovery from block followed a biphasic time course with fast and slow time constants of 3.5 ± 0.7 and 100.3 ± 15.4 ms, respectively. Using N-methyl-cocaine, a permanently charged, membrane-impermeable cocaine analog, block of HERG channels rapidly developed when the drug was applied intracellularly through the patch pipette, suggesting that the cocaine binding site on the HERG protein is located on a cytoplasmic accessible domain. These results indicate that cocaine suppresses HERG, but not KvLQT1+minK, channels by preferentially blocking activated channels, that it unblocks upon repolarization, and does so with unique ultrarapid kinetics. Because the cocaine concentration range we studied is achieved in humans, HERG block may provide an additional mechanism for cocaine-induced arrhythmias and sudden death.
AB - Cocaine causes cardiac arrhythmias, sudden death, and occasionally long QT syndrome in humans. We investigated the effect of cocaine on the human K+ channels HERG and KvLQT1+mink that encode native rapidly (IKr) and slowly (lKs) activating delayed rectifier K+ channels in the heart. HERG and KvLQT1+mink channels were heterologously expressed in human embryonic kidney 293 cells, and whole-cell currents were recorded. Cocaine had no effect on KvLQT1+mink current in concentrations up to 200 μM. In contrast, cocaine reversibly blocked HERG current with half-maximal block of peak tail current of 7.2 μM. By using a protocol to quickly activate HERG channels, we found that cocaine block developed rapidly after channel activation. At 0 mV, the time constants for the development of block were 38.2 ± 2.1, 15.2 ± 0.8, and 6.9 ± 1.1 ms in 10, 50 and 200 μM cocaine, respectively. Cocaine-blocked channels also recovered rapidly from block after repolarization. At -100 mV, recovery from block followed a biphasic time course with fast and slow time constants of 3.5 ± 0.7 and 100.3 ± 15.4 ms, respectively. Using N-methyl-cocaine, a permanently charged, membrane-impermeable cocaine analog, block of HERG channels rapidly developed when the drug was applied intracellularly through the patch pipette, suggesting that the cocaine binding site on the HERG protein is located on a cytoplasmic accessible domain. These results indicate that cocaine suppresses HERG, but not KvLQT1+minK, channels by preferentially blocking activated channels, that it unblocks upon repolarization, and does so with unique ultrarapid kinetics. Because the cocaine concentration range we studied is achieved in humans, HERG block may provide an additional mechanism for cocaine-induced arrhythmias and sudden death.
UR - http://www.scopus.com/inward/record.url?scp=0035033770&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035033770&partnerID=8YFLogxK
U2 - 10.1124/mol.59.5.1069
DO - 10.1124/mol.59.5.1069
M3 - Article
C2 - 11306689
AN - SCOPUS:0035033770
SN - 0026-895X
VL - 59
SP - 1069
EP - 1076
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 5
ER -